MY CHOICE Levonorgestrel Tablets Recalled for Storage Temperature Deviation
Family Dollar Stores is recalling MY CHOICE Levonorgestrel Tablets due to storage temperature deviations that may affect product efficacy. The tablets were distributed nationwide between April 30 and June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall due to storage temperature deviations affecting a pharmaceutical product. With no reported illnesses or injuries, the hazard is potential loss of efficacy rather than acute harm.
Plain-English summary
Family Dollar Stores, Llc. is recalling MY CHOICE Levonorgestrel Tablets due to a manufacturing compliance issue. The recalled products were stored outside appropriate temperature conditions, which may affect their efficacy.
The affected tablets were distributed to Family Dollar Stores nationwide between April 30, 2022 and June 10, 2022. The product SKU is 998211.
Consumers who purchased this product during the specified time period should consult with a healthcare provider or pharmacist to discuss whether their tablets may be affected and whether a replacement product is needed.
The recalled product
- Product
- MY CHOICE LEVONORGESTREL TABLET distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Emergency Contraceptive
- Hazard
- storage-temperature-deviation
- reduced-efficacy
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 998211
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27